FirmaIQ
Org.nr 994 576 313 2023 → 2024 Year-over-year analysis

ABC BIOSCIENCE AS: årsregnskap 2024 vs 2023

Cash halved-plus, fresh owner capital

approved 2025-06-30; registry 2025-07-19; journal 2025 676540

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2024 with 2023 for ABC BIOSCIENCE AS. Revenue 0 NOK → 0 NOK (0.0%). Net result +19.7k NOK → +20.5k NOK. Equity 4.16m NOK → 4 NOK.

On the constructive side: owners injected capital. Pressures included: operating result weakened; equity eroded; cash fell.

Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for ABC BIOSCIENCE AS.

At a glance

Scorecard

Revenue
0 NOK 0 NOK
0.0%
Operating result
-14.0k NOK -15.4k NOK
-10.2%
Net result
+19.7k NOK +20.5k NOK
+3.7%
Equity
4.16m NOK 4 NOK
-100.0%
Cash
869.1k NOK 185.4k NOK
-78.7%
Total assets
869.1k NOK 536.5k NOK
-38.3%

What improved

  • ↑

    Owners injected capital

    Paid-in equity rose 143.2k NOK → 494.4k NOK (+351.2k NOK). Reported fact

What deteriorated

  • ↓

    Operating result weakened

    Operating result -14.0k NOK → -15.4k NOK. Calculated

  • ↓

    Equity eroded

    Book equity 4.16m NOK → 4 NOK (equity ratio 479.2% → 0.0%). Calculated

  • ↓

    Cash fell

    Bank deposits 869.1k NOK → 185.4k NOK (-78.7% YoY). Calculated

Things to notice

  • ·

    Thin equity buffer

    Equity ratio is 0.0% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation